- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Products (Recombinant protein) | Swiss Prot# | Size | Price (US$) | Order |
PL0232 | Recombinant protein-Entamoeba histolytica Serine rich protein (a.a.18 to 170) | Q94563 | 100 µg | 1195 | |
PL0233 | Recombinant protein-Entamoeba histolytica Saliva IgA-recognized antigen (a.a. 18 to 160) | Q94562 | 100 µg | 1195 | |
PL0234 | Recombinant protein-Entamoeba histolytica cysteine surface protein (a.a.61 to 460) | Q9BI07 | 100 µg | 1195 | |
PL0235 | Recombinant protein-Entamoeba histolytica-Herring worm-protein (a.a.1 to 98) | Q9GPI1 | 100 µg | 1195 | |
PL0236 | Recombinant protein-Entamoeba histolytica Adhesin (a.a.61 to 460) | Q9U7F6 | 100 µg | 1195 | |
PL0237 | Recombinant protein-Entamoeba histolytica Pyruvate- phosphate dikinase (a.a.61 to 460) | P37213 | 100 µg | 1195 | |
PL0238 | Recombinant protein-Entamoeba histolytica Antigen (a.a.21 to 335) | Q24843 | 100 µg | 1195 | |
PL0239 | Recombinant protein-Entamoeba histolytica Rho-related protein racG (a.a.18 to 199) | O76321 | 100 µg | 1195 | |
PL0240 | Recombinant protein-Entamoeba histolytica Surface antigen protein (a.a.21 to 294) | Q24847 | 100 µg | 1195 | |
PL0241 | Recombinant protein-Entamoeba histolytica Cysteine protease (a.a.17 to 446) | Q9U7F7 | 100 µg | 1195 | |
PL0242 | Recombinant protein-Entamoeba histolytica HM-1 Surface antigen ariel1(a.a.18 to 155) | B1N5X6 | 100 µg | 1195 | |
PL0243 | Recombinant protein-Entamoeba histolytica HM-1 Proliferating cell nuclear antigen (a.a.21 to 262) | C4M9R9 | 100 µg | 1195 | |
PL0244 | Recombinant protein-Entamoeba histolytica HM-1 Cysteine-rich surface protein (a.a.15 to 252) | C4LVF2 | 100 µg | 1195 | |
PL0245 | Recombinant protein-Entamoeba histolytica HM-1 Serine-rich 25 kDa antigen protein (a.a.21 to 235) | B1N5L1 | 100 µg | 1195 | |
PL0246 | Recombinant protein-Entamoeba histolytica HM-1 Cell surface protease gp63 (a.a.61 to 460) | C4M655 | 100 µg | 1195 | |
PL0247 | Recombinant protein-Entamoeba histolytica HM-1 Variant surface protein (a.a.10 to 157) | B1N5Q9 | 100 µg | 1195 | |
PL0248 | Recombinant protein-Entamoeba histolytica HM-1 Proliferating-cell nucleolar antigen p120 (a.a.31 to 495) | C4LWT4 | 100 µg | 1195 | |
PL0249 | Recombinant protein-Entamoeba histolytica HM-1 Immuno-dominant variable surface antigen (a.a.61 to 460) | C4M0X6 | 100 µg | 1195 | |
PL0250 | Recombinant protein-Entamoeba histolytica HM-1 Surface antigen ariel1(a.a.1 to 119) | B1N5V0 | 100 µg | 1195 | |
PL0251 | Recombinant protein-Entamoeba histolytica HM-1 Cysteine surface protein (a.a.31 to 428) | B1N3B3 | 100 µg | 1195 | |
PL0252 | Recombinant protein-Entamoeba histolytica HM-1 20 kDaantigen (a.a.21 to 212) | C4M6Y3 | 100 µg | 1195 | |
PL0253 | Recombinant protein-Entamoeba histolytica HM-1 CLL-associated antigen KW-2(a.a.21 to 210) | C4M0V5 | 100 µg | 1195 | |
PL0254 | Recombinant protein-Entamoeba histolytica HM-1 Early endsome antigen 1(a.a.61 to 460) | C4M9D8 | 100 µg | 1195 | |
RPL0232 | cDNA-Entamoeba histolytica Serine rich protein (a.a.18 to 170) | Q94563 | 2 µg | 912 | |
RPL0233 | cDNA-Entamoeba histolytica Saliva IgA-recognized antigen (a.a. 18 to 160) | Q94562 | 2 µg | 852 | |
RPL0234 | cDNA-Entamoeba histolytica cysteine surface protein (a.a.61 to 460) | Q9BI07 | 2 µg | 2394 | |
RPL0235 | cDNA-Entamoeba histolytica-Herring worm-protein (a.a.1 to 98) | Q9GPI1 | 2 µg | 800 | |
RPL0236 | cDNA-Entamoeba histolytica Adhesin (a.a.61 to 460) | Q9U7F6 | 2 µg | 2394 | |
RPL0237 | cDNA-Entamoeba histolytica Pyruvate- phosphate dikinase (a.a.61 to 460) | P37213 | 2 µg | 2394 | |
RPL0238 | cDNA-Entamoeba histolytica Antigen (a.a.21 to 335) | Q24843 | 2 µg | 1884 | |
RPL0239 | cDNA-Entamoeba histolytica Rho-related protein racG (a.a.18 to 199) | O76321 | 2 µg | 1086 | |
RPL0240 | cDNA-Entamoeba histolytica Surface antigen protein (a.a.21 to 294) | Q24847 | 2 µg | 1638 | |
RPL0241 | cDNA-Entamoeba histolytica Cysteine protease (a.a.17 to 446) | Q9U7F7 | 2 µg | 2574 | |
RPL0242 | cDNA-Entamoeba histolytica HM-1 Surface antigen ariel1(a.a.18 to 155) | B1N5X6 | 2 µg | 822 | |
RPL0243 | cDNA-Entamoeba histolytica HM-1 Proliferating cell nuclear antigen (a.a.21 to 262) | C4M9R9 | 2 µg | 1446 | |
RPL0244 | cDNA-Entamoeba histolytica HM-1 Cysteine-rich surface protein (a.a.15 to 252) | C4LVF2 | 2 µg | 1422 | |
RPL0245 | cDNA-Entamoeba histolytica HM-1 Serine-rich 25 kDa antigen protein (a.a.21 to 235) | B1N5L1 | 2 µg | 1284 | |
RPL0246 | cDNA-Entamoeba histolytica HM-1 Cell surface protease gp63 (a.a.61 to 460) | C4M655 | 2 µg | 2394 | |
RPL0247 | cDNA-Entamoeba histolytica HM-1 Variant surface protein (a.a.10 to 157) | B1N5Q9 | 2 µg | 882 | |
RPL0248 | cDNA-Entamoeba histolytica HM-1 Proliferating-cell nucleolar antigen p120 (a.a.31 to 495) | C4LWT4 | 2 µg | 2784 | |
RPL0249 | cDNA-Entamoeba histolytica HM-1 Immuno-dominant variable surface antigen (a.a.61 to 460) | C4M0X6 | 2 µg | 2394 | |
RPL0250 | cDNA-Entamoeba histolytica HM-1 Surface antigen ariel1(a.a.1 to 119) | B1N5V0 | 2 µg | 708 | |
RPL0251 | cDNA-Entamoeba histolytica HM-1 Cysteine surface protein (a.a.31 to 428) | B1N3B3 | 2 µg | 2382 | |
RPL0252 | cDNA-Entamoeba histolytica HM-1 20 kDaantigen (a.a.21 to 212) | C4M6Y3 | 2 µg | 1146 | |
RPL0253 | cDNA-Entamoeba histolytica HM-1 CLL-associated antigen KW-2(a.a.21 to 210) | C4M0V5 | 2 µg | 1134 | |
RPL0254 | cDNA-Entamoeba histolytica HM-1 Early endsome antigen 1(a.a.61 to 460) | C4M9D8 | 2 µg | 2394 |
Entamoeba histolytica cDNA and recombinant antigen
Entamoeba histolytica is a protozoan parasite that causes amoebiasis, a disease that affects millions of people worldwide. One of the most significant factors in the pathogenesis of this disease is the presence of various antigens that interact with the host immune system. In this article, we will explore the different antigens of Entamoeba histolytica and their role in the development and progression of amoebiasis.
Serine-rich proteins are a group of proteins present in Entamoeba histolytica, which have been implicated in the pathogenesis of the disease. These proteins are involved in the adherence and invasion of host cells, which allows the parasite to establish infection. The serine-rich protein family comprises several members, including the serine-rich 25 kDa antigen protein, which is recognized by the host immune system and is associated with a protective immune response.
The saliva IgA-recognized antigen of Entamoeba histolytica is a protein that is recognized by the host immune system and is associated with protective immunity. This antigen is present in the saliva of infected individuals and is involved in the establishment of infection by binding to host cells and facilitating the invasion process.
Cysteine surface proteins are a group of proteins that are present on the surface of Entamoeba histolytica and play a crucial role in the pathogenesis of the disease. These proteins are involved in the adherence and invasion of host cells, as well as in the evasion of the host immune system. Cysteine proteases are another group of proteins that are involved in the pathogenesis of amoebiasis, as they are responsible for the degradation of host tissue and the modulation of the host immune response.
Herring worm-protein is a protein present in Entamoeba histolytica that has been implicated in the pathogenesis of the disease. This protein is involved in the adherence and invasion of host cells and is associated with the pathogenicity of the parasite.
Adhesin is a protein that is present in Entamoeba histolytica and is involved in the adherence of the parasite to host cells. This protein plays a crucial role in the pathogenesis of the disease by facilitating the invasion process.
Phosphate dikinase is a protein present in Entamoeba histolytica that is involved in the energy metabolism of the parasite. This protein plays a crucial role in the survival of the parasite and is essential for the establishment and maintenance of infection.
Rho-related protein racG is a protein that is present in Entamoeba histolytica and is involved in the actin cytoskeleton dynamics of the parasite. This protein plays a crucial role in the motility and invasion of the parasite and is associated with the pathogenesis of the disease.
Surface antigen protein is a group of proteins that are present on the surface of Entamoeba histolytica and play a crucial role in the pathogenesis of the disease. These proteins are involved in the adherence and invasion.
The cysteine surface protein is an important virulence factor of Entamoeba histolytica, a protozoan parasite that causes amoebiasis, a serious and sometimes fatal intestinal infection. This protein plays a key role in the invasion of host tissues by the parasite, by facilitating the attachment of the parasite to host cells. The cysteine surface protein is also involved in the formation of cysts, which are the dormant and highly infectious forms of the parasite that can persist outside the host for extended periods of time.
The herring worm-protein is a protein that is found in the parasitic nematode Herring worm, which infects fish and other marine animals. This protein is a component of the parasite’s outer surface and is thought to be involved in its ability to evade the host’s immune system. The herring worm-protein is also believed to play a role in the parasite’s ability to infect and penetrate host tissues.
Adhesin is a protein that is found in a wide range of organisms, from bacteria to animals, and is involved in the attachment of these organisms to host tissues. In Entamoeba histolytica, the adhesin protein plays a key role in the invasion of host tissues by the parasite, by facilitating the attachment of the parasite to host cells. This protein is also involved in the formation of cysts, which are the dormant and highly infectious forms of the parasite that can persist outside the host for extended periods of time.
Phosphate dikinase is an enzyme that is involved in the metabolism of phosphate, an essential nutrient for many organisms. In Entamoeba histolytica, the phosphate dikinase enzyme plays a key role in the energy metabolism of the parasite, by catalyzing the transfer of phosphate groups between different molecules. This enzyme is also believed to play a role in the pathogenesis of amoebiasis, by contributing to the survival and growth of the parasite within host tissues.
The Rho-related protein racG is a small GTPase that is involved in a wide range of cellular processes, including cell migration, adhesion, and proliferation. In Entamoeba histolytica, the racG protein plays a key role in the invasion of host tissues by the parasite, by regulating the actin cytoskeleton and promoting the formation of cell protrusions that allow the parasite to move and penetrate host tissues.
The surface antigen protein is a protein that is found on the surface of many cells and is involved in a wide range of cellular processes, including cell adhesion, signaling, and recognition. In Entamoeba histolytica, the surface antigen protein plays a key role in the invasion of host tissues by the parasite, by facilitating the attachment of the parasite to host cells. This protein is also involved in the formation of cysts, which are the dormant and highly infectious forms of the parasite that can persist outside the host for extended periods of time.
The cysteine protease is an enzyme that is involved in the degradation of proteins, and is found in many organisms, including bacteria, plants, and animals. In Entamoeba histolytica, the cysteine protease plays a key role in the pathogenesis of amoebiasis, by degrading host tissues and contributing to the spread of the parasite within the host. This enzyme is also involved in the formation of cysts, which are the dormant and highly infectious forms of the parasite that can persist outside the host for extended periods of time.
The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.
Entamoeba histolytica cDNA and recombinant antigens can be used to develop a range of diagnostic and therapeutic applications. Diagnostic applications include the development of rapid, simple and inexpensive tests for the detection of E. histolytica infection. cDNA and recombinant antigens can be used to create both antibody-based and nucleic acid-based diagnostic tests. Molecular methods such as PCR and ELISA can be used to detect the presence of E. histolytica in clinical specimens. In addition, recombinant antigens can be used to create vaccines to protect against E. histolytica infection. Vaccines based on E. histolytica cDNA and recombinant antigens have been developed and are in various stages of testing. Finally, recombinant antigens can also be used to develop drugs that target specific molecules in E. histolytica, such as enzymes or toxins. These molecules can be used to inhibit the growth or survival of the parasite, leading to an effective treatment of E. histolytica infection.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple